🟢 Picard Medical is trading 8.6% up with no clear company-specific catalyst

Picard Medical is trading at $4.69, up 8.56%, with no clear company-specific announcement explaining the move.

• Available company-news listings show no October 2 catalyst.
• Broader markets rose after September payrolls came in at 29,000, below expectations, easing near-term rate-hike concerns. Reuters reported the S&P 500 up 0.68% and the Nasdaq up 1.14%.
• The broad risk-on backdrop may have been supportive, but does not establish the specific cause of Picard Medical’s gain.